RecruitingNCT06244433
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Risk Stratification of Sudden Unexpected Death in Infant Based on Biomarkers - Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Sponsor
Nantes University Hospital
Enrollment
650 participants
Start Date
Aug 27, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios
Eligibility
Inclusion Criteria5
- Death of a child between 0 and 2 years of age due to sudden unexpected death in infant
- Child included in the French SUDI registry with effective participation in the biocollection
- Biological parents of the child included in the BIOMINRISK study
- Parents who have both signed the consent form for blood collection and inclusion of their samples in the biocollection
- parents beneficiaries of a social security or similar scheme
Exclusion Criteria4
- Presence of a known metabolic, genetic or syndromic pathology at the time of death
- Parents Exclusion Crtiteria:
- Parent under guardianship
- Presence of a known metabolic, genetic or syndromic pathology
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
GENETICwhole genome sequencing
Study of all coding and non-coding sequences in the genome to identify pathogenic allelic variants
Locations(15)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06244433